Biosight
Growth/LateBiosight raised €12M in a Growth/Late round in May 2016. The company is based in Karmiel, Israel. Investors in the round: Arkin Holdings, Michael Ilan Management and Investments, Primera Capital. Data as of Nov 2026.
Amount raised
€12M
€11,800,000
Native amount
11,800,000 EUR
Stage
Growth/Late
growth equity
Investors
3
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €12M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
3 namedDate
May 2016
Round type
growth equity
Amount (EUR)
€12M